Table 4.

Differences in plasma lipids among the 2481 participants with MetS included in the study according to statin use

Plasma lipids	Participants not using statins (n = 2018)	Participants using statins (n = 463)	P value
Total cholesterol (mmol/L)	5.38 (5.30, 5.45)	4.38 (4.28, 4.49)	< 0.0001
LDL-cholesterol (mmol/L)	3.29 (3.22, 3.35)	2.31 (2.21, 2.40)	< 0.0001
HDL-cholesterol (mmol/L)	1.07 (1.05, 1.09)	1.03 (1.00, 1.06)	0.03
Non–HDL-cholesterol (mmol/L)	4.31 (4.23, 4.38)	3.35 (3.25, 3.45)	< 0.0001
Triglycerides (mmol/L)	2.22 (2.15, 2.29)	2.27 (2.17, 2.37)	0.40

Data are presented as adjusted mean (95% confidence interval). Linear regression models were used (general linear model [GLM] procedure) with adjustments for sex, age, annual household income, smoking status, physical activity level, self-reported history of high blood pressure, body mass index, energy intake, alternative healthy eating index, and alcohol consumption.

HDL, high-density lipoprotein; LDL, low-density lipoprotein; MetS, metabolic syndrome.